Exclusive investor-only Longevity conference announced

A group of Swiss investors and entrepreneurs targets the global Longevity investor community with an exclusive approach.

Longevity is set to be one of the largest investment opportunities of the near future; with that in mind, the Longevity Investors Conference is curating a programme of top-class speakers from all over the world, including David Sinclair, Aubrey de Grey and Emil Kendziorra, with new speakers being announced shortly.

Longevity.Technology: Following on from the success of our Longevity Investing programme at Longevity2020, Longevity.Technology is proud to be the official media partner of The Longevity Investors Conference.

Set to provide relevant insights into the subject, expert education, investment opportunities and networking – the online conference is targeting private and institutional investors from (U)HNWIs, Family Offices, VCs, Private Equity Funds, Private Banks and Asset Managers. As well as a focus on the most relevant Longevity investors and fund activity, sub-topics include life-extension and cryonics.


“The longevity industry is highly attractive for investors. We see a lack of education and information for investors and want to change this …”



Co-organiser Dr Tobias Reichmuth is excited by the plan: “The longevity industry is highly attractive for investors. We see a lack of education and information for investors and want to change this. While there are scientific-oriented conferences, a professional and global investor focused longevity conference was missing so far.”

Marc P Bernegger, co-organiser (main image), adds “The recent progress in radical life extension is very impressive and creates unique and massive investment opportunities.”

The event takes-place on 1 October 2020, however, the team is already planning 2021, and next year’s conference will be held at the prestigious Suvretta House in St Moritz in Switzerland.

Stay-tuned for updates as we get closer to the content and speakers over the coming months.

Applications open via this link.

Eleanor Garth
Staff Writer and Community Manager Following a degree in Classics, Eleanor organised biomedical engineering conferences and provided research support at Imperial College London and various London hospitals, before working as a science and medicine journalist.

Latest articles

VC enters Longevity market with K4Connect deal

We talk with VC investor Forte Ventures about its first foray into AgeTech, COVID-19 and the Longevity investment opportunity. Longevity agetech company K4Connect has announced...

Challenging the one drug/one disease model

A new paper supports the targeting of aging processes, rather than just one disease, to improve Longevity outcomes. Multimorbidity is a challenge for Longevity; defined...

Robotics and AI combine for new therapeutics discovery

Insilico Medicine and Arctoris announce robotics/AI partnership to focus on COVID-19 inhibitors that could have wide-reaching benefits for Longevity. Two companies have joined forces in...

The results are in: sharing our Longevity investment survey

There is rapidly-increasing activity in both the research and the investment communities that focus on Longevity; this survey gets into the details. The global Longevity...